Prostate cancers in men with low PSA levels--must we find them?
about
Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening.Cancer diagnosis in primary careDistribution of PSA velocity by total PSA levels: data from the Baltimore Longitudinal Study of Aging.Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion.The search for secreted proteins in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of NBL1 is highly restricted to the prostate and is related to cancer progression.Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?A Review on the Clinical Utility of PSA in Cancer ProstateMutation screening and association study of RNASEL as a prostate cancer susceptibility gene.Accuracy of a high prostate-specific antigen level for prostate cancer diagnosis upon initial biopsy in Korean men.Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemopreventionDigital rectal examination as a prostate cancer-screening method in a country with a low incidence of prostate cancer.Update on Screening for Urological Malignancies.Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.
P2860
Q30402074-E893A2A0-BF03-47A5-BE91-D5C98FE74ECDQ33622291-305923D7-BF54-4DEA-AC49-D5EB8A8E0729Q33783135-E75D1517-4B2D-405B-853D-ADC0643FC8F5Q33989110-161F32F1-F6C9-4E22-8647-3222C15557A0Q33995454-A3697DE1-805F-45ED-AD00-F85ED7D4EE8FQ34403242-73088E65-447C-4DC5-BE98-6906F4020EFDQ36018610-DD9A3E95-C852-4BA8-9C42-C8F36B8EF3EFQ36084063-0F9ECDF2-6A19-49D7-B418-1BD866175A7BQ36616492-E5C1C011-2A7F-4B3A-8CC1-B4EEF1F3038DQ37065290-ACBC2215-C983-452D-92A4-2CA1118DFB3BQ37104344-EF876263-4259-402D-9CBB-D007028B3BC6Q37700962-C4B07FA0-D5B9-4CB8-AF6A-4D992DF6C353Q39786539-F9E72FB0-69F3-407B-989B-8C1831D73151Q42649779-D454CA57-112B-4357-955E-E17EA07EF9A9Q50804094-9F16A232-2DF5-425E-B122-101B7C4B9532
P2860
Prostate cancers in men with low PSA levels--must we find them?
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Prostate cancers in men with low PSA levels--must we find them?
@ast
Prostate cancers in men with low PSA levels--must we find them?
@en
Prostate cancers in men with low PSA levels--must we find them?
@nl
type
label
Prostate cancers in men with low PSA levels--must we find them?
@ast
Prostate cancers in men with low PSA levels--must we find them?
@en
Prostate cancers in men with low PSA levels--must we find them?
@nl
prefLabel
Prostate cancers in men with low PSA levels--must we find them?
@ast
Prostate cancers in men with low PSA levels--must we find them?
@en
Prostate cancers in men with low PSA levels--must we find them?
@nl
P2860
P356
P1476
Prostate cancers in men with low PSA levels--must we find them?
@en
P2093
H Ballentine Carter
P2860
P304
P356
10.1056/NEJME048003
P407
P577
2004-05-27T00:00:00Z